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SUMMARY
We describe a chemical method to label and purify 4-thiouridine (s4U)-containing RNA. We 
demonstrate that methanethiosulfonate (MTS) reagents form disulfide bonds with s4U more 
efficiently than the commonly used HPDP-biotin, leading to higher yields and less biased 
enrichment. This increase in efficiency allowed us to use s4U-labeling to study global microRNA 
(miRNA) turnover in proliferating cultured human cells without perturbing global miRNA levels 
or the miRNA processing machinery. This improved chemistry will enhance methods that depend 
on tracking different populations of RNA, such as 4-thiouridine-tagging to study tissue-specific 
transcription and dynamic transcriptome analysis (DTA) to study RNA turnover.
INTRODUCTION
RNA is continuously transcribed and degraded in a tightly regulated and transcript-specific 
manner. The dynamics of different RNA populations can be studied by targeted 
incorporation of non-canonical nucleosides. These nucleosides can provide a chemical 
handle for labeling and enriching RNA subpopulations. The labeling of RNA employs 5-
bromouridine (5-BrU; Tani et al., 2012), 5-ethynyluridine (5-EU; Jao and Salic, 2008), and 
4-thiouridine (TU or s4U; Cleary et al., 2005; Miller et al., 2009), which provide different 
vehicles for antibody detection, cycloaddition reactions, and thiol-specific reactivity, 
respectively. 4-thiouridine holds the advantage that labeling is covalent, unlike the antibody 
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detection of 5-BrU, and also that the disulfide bond is reversible, unlike the click chemistry 
used to label 5-EU (reviewed in(Tani and Akimitsu, 2012).
Methods to enrich s4U-incorporated RNA (s4U-RNA) initially relied on organomercurial 
affinity matrices (Melvin et al., 1978), but the use of s4U in metabolic labeling expanded 
after HPDP-biotin, a 2-pyridylthio-activated disulfide of biotin, was developed as a practical 
means to biotinylate s4U-RNA using reversible disulfide chemistry, followed by enrichment 
using a streptavidin matrix (Cleary et al., 2005; Dölken et al., 2008). The s4U-RNAs can be 
eluted by reduction of the disulfide linkage and subsequently analyzed by microarray, 
qPCR, or deep sequencing. This modified protocol sparked a surge in techniques that use 
s4U metabolic labeling. For example, half-lives of specific RNAs can be measured using 
s4U metabolic labeling by quantifying the ratio of pre-existing (flow through) to newly 
transcribed (elution) RNA (Dölken et al., 2008). This approach has been extended to 
genome-wide analysis using high-throughput sequencing (s4U-Seq; Rabani et al., 2011). 
Combining s4U metabolic labeling with dynamic kinetic modeling has led to the 
development of dynamic transcriptome analysis (DTA; Miller et al., 2011), and comparative 
dynamic transcriptome analysis (cDTA) when using S. pombe standards for normalization, 
which allows the determination of absolute rates of mRNA synthesis and decay (Sun et al., 
2012). Reversible transcriptional inhibition has been combined with s4U metabolic labeling 
to measure transcriptional elongation rates (Fuchs et al., 2014). Recently, s4U metabolic 
labeling has been used with approach to equilibrium kinetics to determine absolute RNA 
degradation and synthesis rates based on multiple time points after s4U labeling (RATE-seq; 
Neymotin et al., 2014). In addition to these methods for analyzing RNA turnover, the 
enrichment of s4U-RNA can also be used to determine cell-type specific transcription (4-
thiouridine tagging), which is particularly helpful for analyzing the transcriptomes of cell 
types that are difficult to isolate by dissection or dissociation methods (Miller et al., 2009).
As the efficient chemical modification of s4U is central to all of these techniques, we tested 
the reactivity of s4U with HPDP-biotin. Here we report that the reaction and corresponding 
enrichment of s4U-RNA with HPDP are inefficient. Therefore, we developed and validated 
chemistry using activated disulfides to label and enrich s4U-RNA. This chemistry increases 
labeling yields and decreases enrichment bias. Due to the increased efficiency of this 
chemistry, we were able to extend s4U-metabolic labeling to the study of microRNAs 
(miRNAs), providing insight into miRNA turnover in proliferating cells without inhibition 
of miRNA processing pathways. Our studies expand the utility of s4U in metabolic labeling 
applications and provide the foundation for clearer insight into cellular RNA dynamics 
through the improvement of all the methods listed above.
DESIGN
We sought chemistry to enrich s4U-RNA that satisfied several considerations. First, the 
chemistry should be efficient, leading to high yields of labeled s4U residues. To maintain the 
advantages of reversible covalent chemistry, we focused on activated disulfide reagents, 
which allow reductive release after enrichment. This labeling chemistry should be rapid, 
minimizing time required for purification and decreasing RNA degradation during handling. 
Finally the chemistry needs to be specific for s4U and should not react with RNA that lacks 
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thiol groups. These improvements would lead to a more robust protocol for s4U-RNA 
isolation. Additionally, optimized chemistry could allow the extension of labeling to small 
RNAs including miRNAs. Smaller RNAs are expected to be particularly sensitive to the 
efficiency of s4U labeling, as they tend to have fewer uridine residues and therefore have 
lower probability of successful labeling. To develop chemistry that meets the above criteria, 
we first used simple chemical systems to determine the reactivity of activated disulfides. We 
studied the specificity of labeling chemistry using synthetic RNA with and without s4U. We 
used metabolic labeling experiments together with RNA-sequencing (RNA-Seq) to test the 
application of this chemistry in the context of complex RNA samples. Finally, we evaluated 
the use of this chemistry to study miRNA turnover, revealing fast- and slow-turnover 
miRNAs in proliferating cells without perturbing miRNA processing pathways.
RESULTS
Optimizing labeling chemistry using free nucleosides
To examine the reactivity of s4U-RNA with HPDP-biotin, we first studied the labeling of 
the s4U nucleoside using liquid chromatography coupled to mass spectrometry (LC-MS; 
Figure 1A, B). We found biotinylation of the s4U nucleoside with HPDP-biotin to be 
inefficient when using buffer conditions that are commonly used in the retrieval of s4U-
RNA (Gregersen et al., 2014). This inefficiency stems from the forward and reverse 
disulfide exchange reactions (Figure 1A). Any disulfide formed with the electron-poor 
pyrimidine ring of s4U results in a more activated product, therefore favoring the reverse 
rather than the forward labeling reaction. For this reason, it is not surprising that HPDP-
biotin is an inefficient reagent for disulfide exchange with s4U. Improving this chemistry 
would expand the utility of s4U, improve the sensitivity of s4U labeling, and reduce bias in 
s4U-RNA enrichment.
Of the numerous activating chemistries used to make asymmetric disulfides (Jeschke, 2013; 
Kenyon and Bruice, 1976), thiosulfates and alkylthiosulfonates are particularly attractive 
(Figure 1C). We found that, in sharp contrast to the slow and inefficient reaction with 
HPDP-biotin, methylthiosulfonate-activated biotin (MTS-biotin) reacts efficiently with s4U, 
leading to >95% conversion to the mixed disulfide within just five minutes (Figure 1D). We 
validated this difference in s4U reactivity between MTS-reagents and 2-pyridylthio-activated 
disulfides using NMR (Figure 1E, Figure S1A–S1C). While only a minority of s4U reacted 
using 2-pyridylthio chemistry (<20%), MTS chemistry led to >95% conversion of s4U to the 
mixed disulfide.
Extending MTS labeling chemistry to s4U-RNA
This MTS-chemistry could be used to specifically fluorescently label s4U-RNA in the 
context of cell extracts (Figure S1D). Furthermore, we found that the use of MTS-biotin 
leads to superior biochemical enrichment of s4U-RNA in comparison to HPDP-biotin 
(compare flow through to eluent in Figure 1F, G) or thiosulfate-biotin (TS-biotin, Figure 
S1E–G). Importantly, MTS- and HPDP-chemistries are specific for enrichment of s4U, as no 
significant enrichment of RNA without s4U occurred in either case (Figure 1F, G, Figure 
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S1H). We therefore conclude that MTS-chemistry provides a specific and highly efficient 
means of detecting and biochemically purifying s4U-RNA.
We next tested the efficacy of MTS-biotin as a reagent to examine newly transcribed RNA 
in HEK293T cells (Figure 2A). We treated cells with s4U-supplemented media and reacted 
the isolated RNA with either HPDP-biotin (as described previously by(Gregersen et al., 
2014) or MTS-biotin. Biotinylated RNA was enriched and then analyzed by RNA-
sequencing (RNA-Seq). To compare the RNA-Seq reads across experiments, we used a 
normalization approach developed by Sun et al. (2012) in which the same amount of RNA 
from S. pombe is added to each sample prior to constructing the library for RNA-Seq. 
Consistent with our prior analysis, compared to HPDP-biotin, the use of MTS-biotin led to 
significantly greater normalized coverage of the human transcriptome (Figure 2B, C). This 
enrichment was reproducible across biological replicates (Pearson’s r = 0.92, Figure S2A–
D) and was validated by qPCR (Figure S2E, F). To test the specificity of MTS chemistry, 
we examined MTS-biotin treated RNA from cells that had not been treated with s4U, and 
found substantially fewer normalized reads than with either HPDP-biotin or MTS-biotin 
enriched s4U-RNA (Figure 2B, C). The result from this control experiment validated the 
specificity of MTS-biotin for metabolically labeled s4U-RNA.
Alleviating length bias using MTS-biotin
We next compared the distributions of enriched RNAs using MTS- and HPDP-biotin. 
Purification of s4U-RNA using HPDP-biotin is reported to bias enrichment toward longer 
RNAs that tend to contain increasing numbers of uridines, hereafter referred to as length 
bias (Miller et al., 2011; Miller et al., 2009). This bias was confirmed in our study (Figure 
2D). While this bias can be partially mitigated statistically (Miller et al., 2011; Miller et al., 
2009), more fruitful biochemical enrichment is clearly preferable, especially when 
examining overlapping transcript models of different sizes (e.g., spliced and unspliced, see 
Supplemental Discussion). To examine how MTS chemistry impacted the length bias in 
comparison with other activated disulfides, we used an in vitro transcribed RNA ladder with 
and without s4U to test the relative yields of RNAs with different lengths. This analysis 
confirmed the presence of a length bias, and agrees well with modeling results (Figure S1G), 
demonstrating how MTS chemistry largely alleviates length bias in RNA turnover 
experiments. Indeed, analysis of our RNA-Seq data reveals that MTS-biotin is less prone to 
length bias compared to HPDP-biotin (Figure 2D). For example, long transcripts like 
MALAT1 (8.7 kb) are isolated by HPDP-biotin and MTS-biotin with approximately equal 
efficiency, whereas shorter transcripts like SCYL1 and LTBP3 (2.3 kb and 3.4 kb, 
respectively, when fully spliced) are found at much greater levels in the MTS-biotin 
pulldown (Figure 2E).
Studying miRNA turnover using MTS-chemistry
Given the substantial increase in s4U-RNA yields we observed when using MTS chemistry, 
we hypothesized that this chemistry could extend s4U metabolic labeling to the study of 
miRNAs. The dynamics of miRNA biogenesis and degradation have gained interest because 
disruption of miRNA homeostasis is implicated in many diseases, particularly for miRNAs 
that regulate progression through the cell cycle (Chang and Mendell, 2007). Generally, 
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miRNA turnover has been investigated by blocking transcription or by inhibiting miRNA 
processing, followed by analysis of miRNA stability (Bail et al., 2010; Gantier et al., 2011; 
Guo et al., 2015). These approaches have demonstrated that while many miRNAs remain 
stable for tens of hours, there are also some miRNAs that turn over much more quickly (e.g., 
miR-222). Extending these studies using metabolic labeling would allow the analysis of 
native miRNA levels in a proliferating system (unlike those studies using transcriptional 
block) without perturbing miRNA biogenesis or global miRNA levels (unlike studies where 
miRNA processing is blocked).
To investigate rates of global miRNA turnover, we treated HEK293T cells with s4U for a 
range of times (Figure 3A) and enriched s4U-miRNAs using MTS chemistry, followed by 
deep sequencing. To test whether s4U perturbs miRNA steady-state levels, we examined 
miRNA levels in cells with and without s4U treatment for 22 days, and we found high 
correlations in miRNA levels (Pearson’s r = 0.99, Figure S3A), demonstrating that s4U 
incorporation has minimal impact on miRNA levels. Our findings are consistent with 
previous accounts that s4U causes minimal perturbation of longer transcripts (Gregersen et 
al., 2014; Hafner et al., 2010), and our own data with longer RNAs (Figure S3B). Consistent 
with our previous results and modeling, a positive control miRNA (a s4U-miRNA spike-in 
added to cellular small-RNAs) was enriched when using MTS-biotin, but was not 
significantly enriched with HPDP-biotin (Figure S3D). We next evaluated the s4U-miRNAs 
at different times after initiating s4U treatment. We found miRNAs levels were reproducibly 
enriched from replicate samples (Figure 3C, S3E). Furthermore, miRNA levels in 
neighboring time points were most similar to each other, and those enriched at later time 
points (1 day, 3 day and 6 days) approached the levels observed at steady state (22 days). As 
expected, the steady-state miRNA levels most closely resembled the input miRNAs levels 
(Figure 3C).
To determine which miRNAs turned over most quickly, we analyzed the relative distribution 
of enriched miRNAs at early time points (20 min) versus steady state (6 days or greater; 
Figure 3D). We identified many RNAs whose relative enrichment was significantly different 
from steady state at early time points, and found these miRNAs displayed a consistent trend 
across time (Figure 3E). We expect fast-turnover miRNAs to be over-represented relative to 
the population in early time points, and slow-turnover miRNAs to be under-represented 
(Figure 3B). To evaluate this expectation, we took advantage of established properties of 
miRNA processing (reviewed in(Rüegger and Großhans, 2012; Winter et al., 2009). During 
miRNA biogenesis, one of the two strands from the duplex precursor generally degrades 
rapidly (referred to here as the miR-star) while the other strand is incorporated into the 
RNA-induced silencing complex (RISC) and exhibits higher stability. Therefore, we 
hypothesized that the miR-star sequences would be over-represented at early time points, 
and this hypothesis was verified: of the 52 significantly enriched and depleted miRNAs 
(FDR < 5x10−5), about one third of the fast-turnover miRNAs were miR-star sequences 
(11/30), while none of the stable miRNAs (0/22) were annotated as miR-star sequences. The 
fast-turnover miRNAs we identified include miRNAs that agree with previous results using 
transcriptional blockade (e.g., miR-222; Guo et al, 2015). Other miRNAs were found to be 
slow turnover (e.g., miR-7), and many of these are also in agreement with past studies (Bail 
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et al., 2010; Guo et al., 2015). In general, our results using metabolic labeling of miRNAs 
agree well with results from analysis of degradation after blocking miRNA production (Bail 
et al., 2010; Guo et al., 2015). There are exceptions, however, such as miR-98-5p and 
miR-191-5p, which were identified as fast-turnover miRNAs in our analysis (Figure 3D, E, 
and Figure S3F for qPCR validation; for a full list of fast-turnover non-star miRNAs, see 
Table S2), yet upon transcriptional blockade these miRNAs are stable (Bail et al., 2010; Guo 
et al., 2015). While these results may be due to tissue or cell line differences, it is more 
likely the faster turnover we observed for miR-98-5p and miR-191-5p is due to the cell cycle 
regulation of these miRNAs (Polioudakis et al., 2015; Ting et al., 2013). Turnover in 
response to progression through the cell cycle is masked when using transcriptional 
inhibition, but this turnover is evident using a metabolic labeling approach to study miRNA 
dynamics in dividing cells, underscoring one of the advantages of this improved chemistry.
DISCUSSION
Together, our results demonstrate that MTS-biotin is a specific reagent that can be used to 
efficiently label and enrich s4U-RNA with higher yields and less bias than the commonly 
used HPDP-biotin. The dramatic improvement over existing s4U biotinylation protocols 
renders MTS chemistry useful for studying dynamics of free nucleosides (Figure 1B, D, E), 
synthetic RNAs (Figure 1F, G), E. coli extracts (Figure S1), and s4U-RNA in metabolic 
labeling experiments (Figure 2). In RNA-turnover experiments, for example, the superior 
MTS chemistry alleviates transcript length bias, decreases the amount of starting material 
required, and may allow for the use of lower doses of s4U to avoid potential toxicities that 
some have observed (Burger et al., 2013), but not others (Gregersen et al., 2014; Hafner et 
al., 2010), when metabolically labeling cells. We demonstrate the utility of this MTS 
chemistry using miRNA RATE-seq, which allowed us to identify fast- and slow-turnover 
miRNAs in proliferating cells with flux through the miRNA pathway (Figure 3). This 
advance provides the foundation for more detailed kinetic analyses of miRNA processing 
and turnover. More generally, applying the chemistry described herein should provide a 
superior means to gain insights into RNA dynamics in diverse biological systems.
LIMITATIONS
This manuscript describes improved capture of s4U-RNA, but the enrichment will only be 
successful when the RNA contains sufficient levels of s4U. In metabolic labeling 
experiments, incorporation of s4U into RNA can be controlled by the concentration of s4U 
during cell treatment and the time of s4U exposure. Insufficient s4U incorporation leads to 
low yields and will also favor enrichment of longer transcripts that have more uridine 
residues (and therefore a greater probability of s4U incorporation). For technical 
considerations while preforming s4U-RNA enrichment see Experimental Procedures and the 
Detailed Protocol included in the Supplemental Material.
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EXPERIMENTAL PROCEDURES
Cell lines and s4U metabolic labeling
HEK293T cells were cultured in high glucose DMEM media supplemented with 10% (v/v) 
fetal bovine serum, and 1% (v/v) 2 mM L-glutamine. For labeling of long RNAs, cultured 
cells at 80% confluence were treated with 700 μM s4U for 60 min, washed with PBS, 
trypsinized, and harvested. Cells were resuspended in TRIzol reagent, flash frozen, and 
stored overnight at −80°C. Cell lysates were chloroform extracted once and total RNA was 
purified by the RNeasy mini kit (Qiagen). For miRNA labeling, cultured cells were grown 
for 6 days and split 1:8 on day 3. Cells were grown in the presence of 100 μM s4U for 22 
days, 6 days, 3 days, 1 day, 9 hr, 3 hr, 1 hr, 20 min, or in the absence of s4U. On day 6, all 
cells were harvested using trypsin and resuspended in TRIzol reagent with exogenous s4U-
containing miRNAs (Dharmacon) and one exogenous non-s4U miRNA (IDT). Samples were 
flash frozen, and stored overnight at −80°C. Cell lysates were chloroform extracted once and 
total RNA purified by the miRvana miRNA isolation kit (Life Technologies).
Purification of s4U-labeled RNA
Biotinylation and s4U-RNA enrichment with HPDP-biotin were carried out based on 
protocols adapted from Gregersen et al. and optimized for MTS-biotin. Reactions were 
carried out in a total volume of 250 μL, containing 70 μg total RNA, 10 mM HEPES [pH 
7.5], 1 mM EDTA, and 5 μg MTSEA biotin-XX (Biotium) or 50 μg HPDP-biotin (Pierce) 
freshly dissolved in DMF (final concentration of DMF = 20%). Reactions were incubated at 
room temperature for 2 hr (HPDP) or 30 min (MTS) in the dark. Following biotinylation, 
excess biotin reagents were removed by addition of 1 volume phenol:chloroform (Sigma), 
followed by vigorous mixing for 15 seconds, 2 min incubation at RT, and centrifugation in a 
Phase-Lock-Gel tube (5Prime) at 12,000 x g for 5 min. Supernatant was removed and RNA 
was precipitated with a 1:10 volume (20 uL) of 5 M NaCl and an equal volume of 
isopropanol (200 uL) and centrifuged at 20,000 x g for 20 min. The pellet was washed with 
an equal volume of 75% ethanol. Purified RNA was dissolved in 50 μL RNase-free water 
and denatured at 65°C for 10 min, followed by rapid cooling on ice for 5 min. Biotinylated 
RNA was separated from non-labeled RNA using μMacs Streptavidin Microbeads 
(Miltenyi). Beads (200 μL) were added to each sample and incubated for 15 min at room 
temperature. In the meantime, μColumns were placed in the magnetic field of the μMacs 
separator and were equilibrated with nucleic acid wash buffer supplied with the beads 
(Miltenyi). Reactions were applied to the μColumns and flow-through was collected as the 
pre-existing RNA fraction. μColumns were washed twice with high salt wash buffer (500 μL 
each, 100 mM Tris-HCl [pH 7.4], 10 mM EDTA, 1 M NaCl, and 0.1% Tween-20). s4U-
RNA was eluted from μColumns with 100 μL freshly prepared 100 mM DTT followed by a 
second elution with an additional 100 μL 5 min later. RNA was recovered from the flow-
through and eluent samples using the MinElute Spin columns (Qiagen) according to the 
instructions of the manufacturer. S. pombe total RNA (11 ng, a generous gift from Julien 
Berro) was added to each sample for downstream normalization.
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s4U-Seq library preparation and sequencing
All sequencing libraries were constructed using standard protocols by the Yale Center for 
Genomic Analysis (YCGA) and run on Illumina HiSeq 2500 instruments. For long RNA-
Seq, strand-specific polyA selected RNA-Seq 5 μg of input and RNA collected from flow-
through and eluted fractions. Samples were multiplexed using Illumina bar codes and 
sequenced using paired-end 2 x 75-nt cycles. For small RNA-Seq, 10% input and RNA 
collected from eluted fractions were used for small RNA library preparation and sequenced 
with single-end 75-nt cycles.
Mapping and quantification of s4U-Seq libraries
For long RNA-Seq, sequencing reads were aligned using Tophat2 (version 2.0.12; Bowtie2 
version 2.2.3), to a joint index of the H. sapiens and S. pombe genomes (hg19 and PomBase 
v22) and transcriptomes (GENCODE v19 and Ensembl Fungi v22; Harrow et al., 2012 and 
Kersey et al., 2013, respectively). Alignments and analysis were performed on the Yale 
High Performance Computing clusters. Following this, we used Cufflinks (version 2.2.1; 
Trapnell et al., 2010) to quantify annotated H. sapiens and S. pombe transcripts, using only 
reads that were uniquely mapped (MAPQ > 20) and that aligned with up to two mismatches 
to the reference.
s4U-Seq normalization
To compare transcript levels between samples, we normalized expression values to S. pombe 
spike-ins as follows:
Where FPKMnorm is the normalized FPKM of a human transcript or gene, FPKMraw is the 
original FPKM calculated for the sample of interest, and Snorm is the slope of the linear 
regression line of raw S. pombe gene FPKMs with the normalizing sample on the y-axis and 
the sample of interest on the x-axis (Figure S2B, Table S1). To normalize genomic coverage 
tracks, we used a similar scheme:
Where Coveragenorm and Coverageraw are the normalized and raw read coverages at a given 
genomic position, and Rsample and Rnorm are the numbers of unique reads in the sample of 
interest and the normalizing sample, respectively. The  adjustment factor reflects that 
we are comparing raw reads, instead of FPKMs. We generated stranded genomic coverage 
tracks using IGVTools (version 2.3.32; Thorvaldsdóttir et al., 2013). For all analyses, we 
normalized to the S. pombe spike in the HPDP-biotin sample. We also accounted for the ten-
fold biochemical dilution of the input samples prior to library preparation by multiplying 
normalized values for these samples by ten.
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Assessment of length bias in eluted s4U-Seq RNA
Because incorporation and biotinylation of s4U are not perfectly efficient, especially when 
using HPDP-biotin, it is expected that transcripts with more uridines will be purified at rates 
greater than or equal to those of shorter transcripts. To assess length bias for each reagent, 
we binned transcript isoforms by numbers of uridines present, and compared the fractions of 
total input RNA that were purified between bins using the Wilcoxon rank-sum test. To avoid 
noise from misassignment of reads between isoforms of individual genes, we included only 
the dominant isoforms of genes (>90% of total expression) in all samples included in the 
analysis. We only included transcripts greater than 200-nt, since shorter transcripts were 
biochemically depleted in the library preparation, and removed transcripts with expression 
levels in the bottom quartile of the input sample.
qPCR assays
For qPCR analysis of long RNA, input or enriched RNA was converted into cDNA with 
VILO reverse-transcription kit (Life Technologies). qPCR was carried out on the CFX96 
real-time system (BioRad) with the iTaq Universal SYBR Green Mix. Results from all 
primers used (listed in Table S3) were corrected for amplification efficiency. For miRNA 
analysis, qPCR was performed using TaqMan miRNA assays (Life Technologies) according 
to the instructions of the manufacturer for the following targets: hsa-miR-7, 
UGGAAGACUAGUGAUUUUGUUG; hsa-miR-20a, 
UAAAGUGCUUAUAGUGCAGGUAG; hsa-miR-98, UGAGGUAGUAAGUUGUA 
UUGUU; hsa-miR-99b, CACCCGUAGAACCGACCUUGCG; hsa-miR-191, 
CAACGGAAUC CCAAAAGCAGCUG; hsa-miR-222, 
AGCUACAUCUGGCUACUGGGUCUC; EED004r, CC 
AUUUGUAUGUUCGGCUAACU; and EED095r; CCAUUUCGCUCGGGUGCUAACU.
miRNA RATE-seq s4U RNA enrichment
Biotinylation and s4U-RNA enrichment were carried out as described above (Purification of 
s4U-labeled RNA) with the following modifications. Excess biotinylation reagent was 
removed using a nucleotide cleanup kit (Qiagen). Following enrichment, RNA was 
concentrated by ethanol precipitation and resuspended in 14 μL RNase-free water. After 
enrichment, samples were supplemented with four synthetic miRNA standards (Dharmacon; 
Table S3).
miRNA RATE-seq bioinformatic analysis
To analyze our smRNA RATE-Seq data, we used a hierarchical mapping pipeline 
combining the sRNAbench (Rueda et al., 2014), Bowtie (Langmead et al., 2009), and 
Bowtie2 tools (Langmead and Salzberg, 2011). Before mapping the reads, we removed 
sequencing adapters, using fastx-clipper (http://hannonlab.cshl.edu/fastx_toolkit/). We then 
proceeded to use Bowtie2 to map reads first to synthetic spikes, and then to the UniVec 
laboratory contaminant database (http://www.ncbi.nlm.nih.gov/tools/vecscreen/univec/) and 
ribosomal RNAs from the GENCODE v19 annotation (Harrow et al., 2012). These two 
categories of sequences that are not expected to produce reads in our miRNA libraries, 
except by contamination or RNA degradation. The remaining unmapped reads were then 
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mapped using sRNAbench, first to the miRBase miRNA 21 annotation (Kozomara and 
Griffiths-Jones, 2013), and then to the entire human genome (hg19). Input reads under 19-nt 
or with greater than one mismatch were removed from all analyses of miRNA and spike 
quantifications.
To perform differential expression analysis between smRNA RATE-Seq time points, we 
used the edgeR package (version 3.2.4; Robinson et al., 2010; Robinson and Smyth, 2007). 
Specifically, we compared three early time points (both 20 min replicates and a deeply 
sequenced 1 hr time point) to three late time points (two 6 day replicates and a 22 day 
sample). miRNA read counts and dispersions were fit to a negative binomial distribution, 
and differential expression was evaluated using the negative binomial exact test. To correct 
for multiple hypothesis testing, we used the Bonferroni correction, and set a family-wise 
error rate of 0.005 to select differentially expressed miRNAs between early time points and 
the steady state.
Mass spectrometry of s4U disulfide exchange
Reactions (50 μL) contained s4U (50 μM), buffer (20 mM HEPES [pH 7.5], 1 mM EDTA), 
and MTS- or HPDP-biotin (5 mM) dissolved in DMF (final concentration of DMF = 5%). 
Aliquots were taken at designated time points and analyzed on an Agilent 6650A Q-TOF 
using a reverse phase column (Thermo Scientific Hypersil GOLD 3 μm, 160 x 2.1 mm) 
detected by electrospray ionization (positive ion mode). Chromatography conditions were 
established based on Sun et al. 2014. Briefly, analysis was initiated with an isocratic 
gradient of 100% buffer A at 0.4 mL/min for 6 min followed by a linear gradient of 0–50% 
buffer B over 6 min, 50–75% buffer B over 2 min, then an isocratic elution at 75% buffer B 
(buffer A: H2O in 0.1% (vol/vol) formic acid; buffer B: acetonitrile in 0.1% (vol/vol) formic 
acid).
NMR of s4U disulfide exchange
Reactions (600 μL) were preformed in D2O containing 10 mM HEPES, s4U (1 mg, 6.4 mM) 
and five equivalents of MeMTS or PDPH dissolved in DMF-δ7 (60 μL, 10% total volume). 
These reactions were incubated in the dark 2 hr for PDPH and 30 min for MeMTS. 
Reactions were analyzed on an Agilent DD2 400 MHz NMR with 16 scans.
Enrichment of singly thiolated RNA
Two fluorescently labeled RNAs were synthesized for s4U enrichment: non-s4U 39-nt RNA 
(DY647 - GGAACCGCCCGGAUAGUGUCCUUGGGAAACCAAGUCCGGGCACCA) 
and one s4U 39-nt RNA (DY547 - 
GGAACCGCCCGGA(s4U)AGUGUCCUUGGGAAACCAAGUCCGGGCACCA) 
(Dharmacon). Biotinylation reactions (50 μL total) contained RNA (1 μM), 10 mM HEPES 
[pH 7.5], 1 mM EDTA, and 25 μM MTS- or HPDP-biotin (dissolved in DMF at 250 μM). 
Reactions were incubated at room temperature in the dark for 30 min or 2 hr, respectively. 
Following biotinylation, excess biotinylation reagenets were removed with two consecutive 
chloroform washes, followed by purification with a nucleotide cleanup kit (Qiagen) 
according to the manufacturer’s instructions. Biotinylated RNA was separated from non-
labeled RNA using Dynabeads MyOne Streptavidin C1 beads (Invitrogen). Biotinylated 
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RNA was incubated with 50 μL Dynabeads with rotation for 1 hr at room temperature in the 
dark. Beads were magnetically fixed and washed twice with Dynabeads high salt wash 
buffer. s4U-RNA was eluted with 100 μL of elution buffer (10 mM Tris [pH 7.4] and 100 
mM DTT). Fractions were concentrated by ethanol precipitation, separated on a 12% urea-
PAGE gel, and visualized by Typhoon fluorescence imager (GE).
Enrichment of an in vitro transcribed RNA ladder
An RNA ladder of 100–1000 nt was transcribed in vitro using the RNA Century Plus 
Marker Template and Maxiscript T7 transcription kit (Invitrogen) using Cy5-CTP at a ratio 
of 1:1 Cy5-CTP:CTP for downstream visualization, with the option of adding s4UTP 
(TriLink Biotechnologies) at a ratio of s4UTP:UTP to the reaction. After the reaction, excess 
nucleotides were removed by an Illustra Microspin G-25 column (GE Healthcare Life 
Sciences) according to the manufacturer’s instructions. RNA ladders were reacted with 
HPDP-, MTS- or thiolsulfonate-biotin (Biotium), following the protocol described above. 
Enriched samples were separated on a 5% urea-PAGE gel, stained with GelGreen and 
visualized by Typhoon fluorescence imager (GE).
Enrichment of thiolated tRNA from E. coli
E. coli WT and ΔthiI cultures were grown to mid-log phase in LB media. Strains were a 
generous gift from Eugene Mueller (Mueller et al., 1998). Cells were pelleted at 3,250 x g 
for 10 min at 4°C. Total RNA was purified by the mirVana miRNA isolation kit (Life 
Technologies). RNA pulldowns were performed as above (Purification of s4U-labeled RNA) 
and fractions separated on a 5% urea-PAGE gel, followed by visualization with GelGreen 
stain.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Current methods to track s4U-RNA are inefficient, giving low yields and high 
bias.
• MTS-chemistry efficiently labels s4U-RNA, which improves methods that rely 
on s4U.
• Increased sensitivity provides greater insight into RNA dynamics and miRNA 
turnover.
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Figure 1. Efficient formation of disulfides with s4U via MTS chemistry
(A) s4U disulfide exchange with HPDP-biotin. (B) LC-MS extracted ion chromatograms of 
s4U (red) and biotin-s4U (blue) for HPDP-biotin at the indicated reaction times. (C) s4U 
disulfide exchange with MTS-biotin. (D) LC-MS chromatograms as in (B). (E) 
Downfield 1H NMR spectra of (top) s4U alone, (center) s4U reacted with 3-[2-
Pyridyldithio]propionyl hydrazide (PDPH), an HPDP-like disulfide, and (bottom) methyl-
MTS. Peaks for the starting material (red shading) and products (blue shading) were 
integrated and normalized to sum of the anomeric protons of s4U and its products (5.9 ppm). 
For full spectra, see Figure S1A–C. (F, G) Enrichment of a singly-thiolated 39-nt RNA by 
(F) HPDP-biotin or (G) MTS-biotin. Fluorescently labeled 39-nt RNAs with or without a 
single s4U were biotinylated with the indicated reagent and enriched on streptavidin beads, 
followed by urea-PAGE and fluorescence imaging. See also Figure S1.
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Figure 2. MTS-biotin affords higher specific yields and lower length bias of s4U-RNA
(A) Schematic of s4U metabolic labeling. 293T cells were treated with s4U (700 μM) for one 
hour, followed by total RNA extraction, biotinylation with either HPDP- or MTS-biotin, and 
enrichment on streptavidin-coated magnetic resin. (B) Total reads for each RNA-Seq sample 
that mapped to the H. sapiens genome, divided by total number of reads that mapped to the 
S. pombe genome. (C) Whole genome alignments of eluted samples from HPDP- or MTS-
biotin enrichments. y-axis indicates number of reads normalized by S. pombe spike-ins (see 
Materials and Methods). Forward and reverse strand reads are represented as positive and 
negative values on the y-axis respectively. To compare coverage between samples on the 
same y-axis scale, in some cases, read coverage exceeds the y-axis upper limit in MTS-
biotin (127 cases) and HPDP-biotin (4 cases). Chromosomes are indicated below the 
mapped reads. (D) Box plot of transcripts recovered by MTS-biotin and HPDP-biotin binned 
by transcript length. Blue = MTS-biotin, purple = HPDP-biotin. (E) Examples of genes 
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enriched by HPDP- and MTS-biotin, along with a no s4U-feed control. MALAT1 (8.7 kb), 
SCYL1 (2.3 kb cDNA) and LTBP3 (3.4 kb cDNA) gene architectures displayed below. See 
also Figure S2, Table S1.
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Figure 3. MTS chemistry reveals fast- and slow-turnover miRNAs in miRNA RATE-seq 
experiments
(A) Schematic of s4U treatments used in miRNA RATE-seq. (B) Cartoon of anticipated 
behavior of fast-turnover and slow-turnover miRNAs in comparison to average. Fast-
turnover miRNAs are expected to be over-represented in the early time points whereas slow-
turnover miRNAs are depleted, relative to steady state (ss). (C) Heatmap depicting 
correlation coefficients (Pearson’s r) between miRNA levels at different times after s4U 
treatment. Replicate samples are indicated by (rep). (D) Volcano plot depicting results from 
a comparative analysis of miRNAs that are significantly enriched or depleted in early time 
points (20 min, 1 hr) relative to steady state levels (6 and 22 days). Fast-turnover miRNAs 
(fold difference early time points from steady state > 4; p-value < 2x10−5; Bonferroni 
family-wise error rate < 0.005) are colored red; slow-turnover miRNAs (fold difference 
early time points from steady state < 0.25; p-value < 2x10−5; Bonferroni family-wise error 
rate < 0.005) are shown in blue. Stars indicate miRNAs defined as miRNA-stars (see 
Experimental Procedures); the others are indicated with circles. (E) Heatmap indicating 
normalized miRNA enrichment relative to steady state level at each time point in RATE-seq 
for the fast- and slow-turnover miRNAs in (C). For clarity of presentation, the most 
significant fast-turnover miRNA in this analysis (miR-4521, log2(fold-change) = 10.8; p-
value = 2.9x10−40) has been omitted from (C) and (D) due to values exceeding the indicated 
scales. See also Figure S5 and Table S2.
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